News | March 16, 2022
Bharat Biotech and Biofabri to develop and distribute novel TB vaccine
MTBVAC is a global public-private project that will be a milestone in the field of vaccinology
MTBVAC is a global public-private project that will be a milestone in the field of vaccinology
Nulibry is approved by the U.S. Food and Drug Administration (USFDA) to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare, life-threatening paediatric genetic disorder
According to statistics, the global inhalation drug market reached US $ 25 billion in 2020
The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol
Company expects strong organic growth in sales, EBITDA in 2022
Serina has over 17 years of experience in the biopharmaceutical industry
The NMPA Breakthrough Therapy Designation was based on results from the Phase 2 TRUST trial of ROS1 fusion-positive NSCLC patients treated with taletrectinib, a new generation of potent ROS1 inhibitors
Thermo Fisher and Symphogen extend their collaboration using innovative and efficient workflows to improve data confidence, aiding the creation of new cancer treatments
Collaboration in the industry needs to be institutionalised to drive the growth.
Adds to Merck’s growing global, multi-modality CDMO network, following newly formed CDMO business unit in Life Science
Subscribe To Our Newsletter & Stay Updated
